Yiqing Du

3PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 09, 2025
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer.

Jilin Wu, Bisheng Cheng, Yuxuan Song

|Jan 11, 2024
FSH Is Responsible for Androgen Deprivation Therapy-Associated Atherosclerosis in Mice by Exaggerating Endothelial Inflammation and Monocyte Adhesion.

Qiang Wang, Jingli Han, Zhenhui Liang

|Oct 02, 2020
Macroscopic somatic clonal expansion in morphologically normal human urothelium.

Ruoyan Li, Yiqing Du, Zhanghua Chen

Pageof 1

Frequent Collaborators

3 joint publications

Tao Xu

1 joint publications

Ruoyan Li

1 joint publications

Zhanghua Chen

1 joint publications

Deshu Xu